Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 2 at 2:00 PM EDT

Register Free →
← Back to NAICS Codes
NAICS Code· 325413

NAICS 325413: In-Vitro Diagnostic Substance Manufacturing

This U.S. industry comprises establishments primarily engaged in manufacturing in-vitro (i.e., not taken internally) diagnostic substances, such as chemical, biological, or radioactive substances. The substances are used for diagnostic tests that are performed in test tubes, petri dishes, machines, and other diagnostic test-type devices. Cross-References.Show more

NAICS 325413 – In-Vitro Diagnostic Substance Manufacturing encompasses the production of reagents, kits, calibrators, controls, and other chemical or biological substances used in laboratory-based diagnostic testing. These products enable the detection, measurement, or monitoring of physiological conditions, infectious agents, biomarkers, and genetic markers in clinical specimens such as blood, urine, and tissue.

51
Active Contracts
$193.7M
Total Obligations (12mo)
1.2K
Awarded Contracts (12mo)
174
Contractors Awarded (12mo)
1
Median Bidders per Award
-75.3%
YoY Growth

Awarded Contractors

Companies that have received federal awards classified under NAICS 325413.

Loading
Dotted
NAICS 325413 FAQ

Frequently Asked Questions

NAICS code 325413 covers In-Vitro Diagnostic Substance Manufacturing. This U.S. industry comprises establishments primarily engaged in manufacturing in-vitro (i.e., not taken internally) diagnostic substances, such as chemical, biological, or radioactive substances. The substances are used for diagnostic tests that are performed in test tubes, petri dishes, machines, and other diagnostic test-type devices. Cross-References.

Recently Posted in In-Vitro Diagnostic Substance Manufacturing

NAICS: 325413
Awarded
DIBBS
WATER SAMPLING TEST
Solicitation # SPE2DH-26-T-4177
The contract solicitation SPE2DH-26-T-4177 seeks the procurement of Colilert 18 reagents for water sampling tests designed to detect fecal coliforms and Escherichia coli, with results required within 18 hours. The item is specified as a unit of issue packaged as PG, with each package containing 200 units, and the entire quantity required is one package. Delivery must be completed within 20 days after award, to the destination APO 09094-3219 under FOB Destination terms. Packaging and marking requirements are strictly defined by Medical Marking Standard No. 1 (MMS No. 1), which supersedes MIL-STD-129, and all units must be sealed in suitable containers to prevent damage during transit. Commercial exterior shipping containers are mandatory, and palletization must adhere to DLA Packaging Requirements for Procurement (RP001). The technical specifications are governed by the DLA Master List of Technical and Quality Requirements, identified by R or I numbers, and the product must be free of any additive manufacturing processes unless explicitly authorized, as inclusion of such items disqualifies an offer. All offers must be submitted through the DIBBS portal by the deadline of June 8, 2026, with inquiries directed to Tina Vu at tina.vu@dla.mil. Offerors are required to maintain current registration in the System for Award Management (SAM), provide their CAGE and Unique Entity Identifier, and ensure compliance with small business set-aside provisions under NAICS code 325998. Contract clauses such as 52.204-13, 52.222-36, 52.222-50, and 52.240-93 apply with deviation 2026-00038, mandating maintenance of SAM data, equal opportunity protections, anti-trafficking policies, and cybersecurity safeguards. Invoicing and receiving reports must be processed electronically via Wide Area Workflow (WAWF), and payment instructions require adherence to DFARS and FAR guidelines. The contractor must also submit hazard warning labels compliant with 29 CFR 1910.1200 prior to award, and government identification must be removed from any non-accepted supplies. Inspection and acceptance will occur at the destination with zero tolerance for quantity variance, and the solic
Defense Logistics Agency

POSTED

3 days ago

DEADLINE

N/A
View Details

Win Contracts in In-Vitro Diagnostic Substance Manufacturing

Get AI-powered intelligence on NAICS 325413 procurement

Real-time contract opportunities for NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing)

AI-powered matching based on your business capabilities and past performance

Competitive analysis of contractors winning awards in this industry

Automated alerts when new opportunities are posted

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS